The Effect of Fabry Disease Therapy on Bone Mineral Density

The Effect of Fabry Disease Therapy on Bone Mineral Density

Fabry disease (FD) is an X-linked lysosomal storage disorder, characterised by the cellular accumulation of globotriaosylceramide due to impaired alpha-galactosidase A enzyme activity. FD may manifest with multisystem pathology, including reduced bone mineral density (BMD). Registry data suggest tha...

Full description

Bibliographic Details
Main Authors: Tess Aitken, Mark K. Tiong, Andrew S. Talbot, Irene Ruderman, Kathleen M. Nicholls
Format: Article
Language:English
Published: MDPI AG 2024-05-01
Series:Diseases
Subjects:
Fabry disease
lysosomal storage diseases
bone mineral density
enzyme replacement therapy
chaperone therapy
Online Access:https://www.mdpi.com/2079-9721/12/5/102

Internet

https://www.mdpi.com/2079-9721/12/5/102

Similar Items